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Abstract
Merkel Cell Polyomavirus (MCPyV) genomes are clonally integrated in tumor tissues of approximately 85% of all Merkel cell
carcinoma (MCC) cases, a highly aggressive tumor of the skin which predominantly afflicts elderly and immunosuppressed
patients. All integrated viral genomes recovered from MCC tissue or MCC cell lines harbor signature mutations in the early
gene transcript encoding for the large T-Antigen (LT-Ag). These mutations selectively abrogate the ability of LT-Ag to
support viral replication while still maintaining its Rb-binding activity, suggesting a continuous requirement for LT-Ag
mediated cell cycle deregulation during MCC pathogenesis. To gain a better understanding of MCPyV biology, in vitro
MCPyV replication systems are required. We have generated a synthetic MCPyV genomic clone (MCVSyn) based on the
consensus sequence of MCC-derived sequences deposited in the NCBI database. Here, we demonstrate that transfection of
recircularized MCVSyn DNA into some human cell lines recapitulates efficient replication of the viral genome, early and late
gene expression together with virus particle formation. However, serial transmission of infectious virus was not observed.
This in vitro culturing system allows the study of viral replication and will facilitate the molecular dissection of important
aspects of the MCPyV lifecycle.
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Introduction
Merkel cell polyomavirus (MCPyV) is one of nine human
polyomaviruses known to date [1–8]; out of these, four (JC, BK,
TSV and MCPyV) are known to induce severe disease in
immunosuppressed patients. MCPyV was identified in 2008 in
primary tumor material from Merkel cell carcinomas (MCC) [2].
Subsequently, up to 85% of all MCC cases were found to carry the
viral DNA monoclonally integrated in the tumor cells [9–13]. The
high frequency of MCPyV detection in MCC tissue, the
monoclonal integration patterns [2,13], and the observation that
the tumor cells constitutively express viral T-antigens strongly
support the classification of MCPyV as a human tumor virus [14].
As in all polyomaviruses, the early region of the MCPyV
genome encodes large and small T Antigens (LT- and ST-Ag,
respectively). These genes are transcribed immediately upon
nuclear delivery of the viral genome and drive the cell into S-
phase, thus creating conditions which are favourable for viral
DNA replication [15]. LT-Ag furthermore exhibits helicase
activity and recruits cellular replication factors to the viral
episome, functions which are of crucial importance for replication
of viral DNA [15]. In addition to LT- and ST-Ag, the early region
of MCPyV also encodes a 57 KDa protein of unknown function,
as well as a viral miRNA that is located in antisense orientation to
the LT-gene; as in other polyomaviruses, this miRNA may serve to
downregulate LT-transcripts during the late stages of the infection
cycle [16].
Strikingly, viral genomes isolated from MCC material unequiv-
ocally carry frameshift or STOP codon mutations within the LT-
Ag coding region, resulting in the expression of truncated LT
proteins that lack the C-terminal origin binding and ATPase/
Helicase domains, and which are thus unable to support viral
replication [13,17]. All MCC-derived LT-Ags, however, maintain
the Rb binding domain, indicating that there is selective pressure
to preserve Rb-inactivating functions during MCC pathogenesis.
At present, when and exactly why viral genomes in MCC acquire
truncating mutations is unclear.
The late gene region of polyomviruses encodes structural
proteins, the major capsid protein VP1 and the minor capsid
proteins VP2 and VP3. All three open reading frames are present
in the MCPyV genome, although VP3 may in fact not be
functional [18]. No agnoprotein has been described for MCPyV so
far [2,19]. Polyomavirus late gene transcription usually is initiated
concomitantly with viral DNA replication [20,21]. In some
members of the polyomavirus family, LT-Ag regulates transcrip-
tion of the structural proteins by binding to the late promoter
region [15]. In SV40, late transcription is independent of viral
replication [21,22]. Polyomavirus assembly and in particular
egress of viral particles from the cell are, despite of extensive
studies in the prototypic SV40 prototype, still incompletely
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is thought to be the primary mechanism of virion release,
accumulation of viral particles in cytoplasmic compartments with
subsequent shedding from intact cells has also been reported
[23,24].
To date, the natural host cell of MCPyV remains elusive;
althoughMCPyVDNAcanbeamplifiedfrom skinswabs ofhealthy
individuals, the amount of DNA recovered is generally rather low
[7,25], and it is therefore unclear whether skin cells represents the
primary reservoir for MCPyV infection. In contrast to the often
broad tissue distribution of polyomavirus receptors, viral replication
and production of infectious progeny is usually highly restricted and
occurs only in few cell types in vitro and in vivo. As a consequence, the
reconstitution of in vitro polyomavirus replication systems is often
challenging. For example, the available in vitro systems to study BK
virus and JC virus infection [26] still only support some aspects of
the viral life cycle, and to date no replication systems has been
established for WU and KI virus [1,4]. To begin addressing the
question of cell type specificity of MCPyV replication, and to
generate a system that allows the study of the MCPyV lifecycle, we
constructed a synthetic consensus MCPyV genome (MCVSyn)
based on all MCPyV sequences available in the NCBI database as
of June 2008. Using this clone, we demonstrate robust and
reproducible viral DNA replication in 3 out of 17 human cell lines
tested. Replication can be significantly enhanced by co-expression
of the early region in trans. Furthermore, we observe early and late
gene transcription in these three cell lines, and detect electron-dense
particleswith asizeof40–50 mmincellstransfected withviralDNA.
Despite of the above, however, we did not observe serial
transmission of MCPyV infection, a finding which is in line with
a recent report that has used an approach similar to ours [27]. We
also provide evidence that MCPyV particles differ from SV40 virus
particles with regard to shape and size, and, using confocal
microscopy, demonstrate that VP1 localization significantly differs
between MCPyV- and SV40-transfected cells. Thus, in addition to
their overall low abundance, low infectivity of MCPyV particles
may be another factor that hampers transmission.
Results
Construction of a synthetic consensus MCPyV genome
(MCVSyn)
The goal of this study was to investigate viral replication in the
context of a full length viral genome. However, at the time when our
study was initiated, no field isolates of MCPyV had been described,
and the only available sequences were derived from the integrated,
defective viral genomes inMCC.Whenwe aligned theses sequences,
weobservedthat,besidesofthe mutationswhich truncatethe LT-Ag
ORF, a number of additional sequence variations were distributed
throughout the viral genome. Some of these variations are likely to
represent nucleotide polymorphisms already present in the parental
MCPyV strain that had originally infected the cell giving rise to the
tumor. However, we could not rule out the possibility that, akin to
the hallmark LT-Ag truncating mutations, some mutations may also
be the result of selectional pressure to abrogate viral replication.
InsteadofrepairingtheSTOPmutationsinoneoftheMCC-derived
clones, we therefore opted to generate a synthetic viral genome
(termed MCVSyn) that represented the consensus of all MCC-
derived MCPyV sequences, reasoning that such a consensus should
come closest to a wild type MCPyV genome. Accordingly, we
aligned all MCPyV sequences deposited in the NCBI database as of
June 2008, and synthetically constructed the full length genome in
two fragments (nts. 1044-4034 and 4003-1056, respectively) in a
bacterial vector backbone. The fragments were subsequently joined
to produce pMCVSyn, a construct from which the full-length
circular viral genome can be produced by restriction digestion and
subsequent intramolecular ligation (see Figure S1 and Material &
Methods for details). The sequences of pMCVSyn and MCVSyn
have been deposited in GenBank under accession numbers
JN707598 and JN707599, respectively.
While our study was in progress, Schowalter et al. [7] reported
the isolation of 20 full-length MCPyV sequences from skin swabs of
healthy individuals. Indeed, our MCC-derived consensus genome is
identicaltothe fieldstrainconsensussequence,which isfurthermore
perfectly preserved in the three individual isolates 17b, 18b and 20b
(acc. numbers HM011549, HM011550 and HM011551, respec-
tively). MCVSyn displays one silent nucleotide exchange in the
VP1-coding region when compared to R17b (Table S1), whereas in
R17a, a single nucleotide deletion can be found in the early
palindrome region of the NCCR. An alignment of the MCVSyn
sequence and seven tumor-derived genomes bearing LT-Ag
mutations as well as 22 non-MCC isolates, including the 20 field
isolates described in [7], is shown in Figure 1 (see Figure S2 for a
phylogenetic tree based on these alignments).
Early gene expression in SV40 and MCVSyn transfected
cells
In order to investigate early gene expression by MCVSyn
genomes, we transfected re-circularized episomes into 12 estab-
lished human cell lines, 3 primary human cell types, 3 african
green monkey cell lines as well as 3 rodent cell lines (Table 1),
followed by RT-PCR and/or western blotting to detect early and
late gene products at various time points post transfection. To
provide an internal control, we performed all assays in parallel
with circularized SV40 DNA transfected into CV-1 cells, a cell line
that is known to be fully permissive for SV40 replication and virion
production. As shown in Figure 2A, SV40 LT-Ag (SDS-resistant
LT-oligomers and monomers as described before [28]) as well as
VP1 protein expression was readily detectable as early as 24 h post
transfection, with both proteins accumulating to high levels over
the following 6 days. Between 4 and 6 days post transfection, the
cultures consistently displayed morphological changes indicative of
early cytopathic effects (i.e., the appearance of rounded and
enlarged cells); all SV40-transfected CV-1 cultures were com-
pletely lysed by day 11 (see Figure S3).
As shown in Table 1, out of the 21 cell lines and primary cell
cultures that had been transfected with MCVSyn DNA, only three
lines consistently showed strong LT-Ag expression when trans-
fected with re-circularized MCVSyn DNA. The protein was most
efficiently expressed in the primitive neuroectodermal tumor cell
line PFSK-I, followed by the human non-small cell lung
carcinoma cell line H1299 and human embryonic kidney 293
cells. However, as shown in Figure 3, in contrast to the
accumulation of LT-Ag protein in SV40-transfected CV-1 cells,
protein expression by MCVSyn reached a peak between 2 and 4
days post transfection, and thereafter declined to levels which were
barely detectable at day 12.
These results suggest that early gene expression in the context of
the full-length MCVSyn episome is efficient in some, but not all of
the tested human cell lines or primary cell cultures. However, since
none of the LT-Ag expressing cells consistently showed a CPE,
and since furthermore LT-Ag expression declined after reaching
an initial peak, we suspected that the virus was unlikely to spread
through the cultures; this could have been due to inefficient viral
DNA replication, a block in the production of mature viral
particles, non-permissiveness of the tested cells for viral entry (e.g.
due to the lack of the authentic entry receptor), or a combination
of the above.
Consensus Merkel Cell Polyomavirus Replication
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PFSK-1 cells
We monitored the efficiency of viral DNA replication in cells
transfected with 100 ng of re-circularized viral genomes at two,
four, eight or twelve days post transfection by isolating episomal
DNA using the HIRT extraction protocol. The DNA was
subsequently digested with EcoRI as well as DpnI and analyzed
by Southern Blotting to detect replicated genomes. In this assay,
non-replicated input plasmids are digested by the restriction
enzyme DpnI, which cleaves methylated dam sites. As eukaryotic
cells lack the bacterial dam methyltransferase, replicated episomes
become resistant to DpnI cleavage. As shown in Figure 2B,
significant amounts of such replicated episomes could already be
detected after one day of transfection of SV40 DNA into CV-1
Figure 1. Alignment of MCVSyn and full length MCPyV sequences. The illustration is based on a multiple sequence alignment using the
Clustal W algorithm (see Table S3 for accession numbers used in the alignment) of MCVSyn and all full length MCPyV sequences deposited in the
NCBI Database as of August 2011. Aligned genomes were compared to the consensus sequence (which is identical to MCVSyn as well as the isolates
17b, 18b and 20b). Nucleotide substitutions/mismatches relative to this sequence are shown as vertical black bars, whereas deletions are shown in
red. Nucleotide insertions in a given sequence are shown as blue bars, and register as gaps in the backbone of the remaining genomes. Genomes
that were isolated from MCC or MCC-derived cell lines are marked by an asterisk; the mutations which lead to the truncation of LT-Ag sequences in
these genomes are likewise marked.
doi:10.1371/journal.pone.0029112.g001
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time, such that at day 8 levels were approximately 2fold higher
than on day 1.
In the three cell lines that had displayed robust LT-Ag after
transfection of MCVSyn genomes, we were also able to readily
detect replicated episomes, albeit with different dynamics and
generally at lower levels than in to SV40 transfected CV-1 cells. In
Figure 4, we show a representative experiment in which
transfection efficiencies between the individual cell lines were
similar (30%; 32% and 40% for H1299, PFSK-1 and 293,
respectively). In all three cell lines, viral DNA replication products
were observed already at the earliest tested time point (i.e., day 2).
However, whereas PFSK-1 cells showed a marked peak of
replication products between four and eight days post transfection,
levels in H1299 and 293 cells continuously increased over the
entire twelve day time course. In H1299 cells, the increase was
more rapid than in 293 cells, reaching final levels of 9.3fold at day
12 (relative to the levels observed at day 2) of the experiment.
Despite of the continuous increase of relative levels observed in
H1299 and 293 cells, however, we consistently observed the
strongest absolute signal intensities in PFSK-1 cells, even though
the peak is only transient. Nonetheless, neither PFSK-1 nor 293 or
H1299 cells showed a CPE, and we were unable to detect LT-Ag
or VP1 expression at late time points of infection (48 days) in these
cultures (data not shown). Interestingly, as shown in Figure 5, the
MCPyV field isolate R17a [7], which differs only by a single
nucleotide deletion in the non-coding palindrome region of the
MCPyV core replication origin ([29], see Figure 1 and Table S1)
reproducibly exhibited an approximately 5 fold lower replication
efficiency in PFSK-1 cells when compared to the MCVSyn
genome.
Although most of the other 18 human, simian or rodent cell
cultures listed in Table 1 scored negative in the above replication
assay, we additionally observed weak and/ortransient replication in
the two primary cell cultures (human umbilical vein-derived
endothelial cells/HUVEC and normal human dermal fibroblasts/
NHDF) as well as the osteosarcoma-derived cell line Saos-2 (Figure
S4). Since we had been unable to detect LT-Ag protein in these cells
inourwesternblots(see Table 1),this observation demonstrates that
low LT-Ag levels that are below our limit of detection are sufficient
to support DNA replication, and furthermore may explain why we
areable toobserve continuedDNAreplicationin293 and H1299 at
late time points post transfection, even though the LT-Ag levels in
these cultures are low (Figure 3).
Constitutive expression of the MCPyV early gene locus in
trans increases viral replication in 293 cells
Given the decline of LT-Ag levels in H2199 and 293 cells over
time, we wondered whether stable provision of LT-Ag in trans may
lead to a further increase in DNA replication efficiency, which in
turn could allow the effective production of infectious viral
progeny. Accordingly, we generated 293 cells which stably express
Table 1. Cell lines used to study MCVSyn replication, early and late transcription as well as particle formation.











CV-1 african green monkey 22 n.t. ,40
Vero african green monkey 22 n.t. ,40
COS-7 african green monkey n.t. ,20
N2A mouse 22 n.t. ,40
NIH3T3 mouse 22 n.t. ,10
pBRK rat 22 n.t. ,5
293 human + + +++ ,60
293T human 22 n.t. ,60
HeLa human 22 n.t. ,40
A549 human (+) 2 n.t. ,40
Bea 2B human 22 n.t. ,20
H1299 human ++ ++ ++ ,40
Saos-2 human (+) 2 n.t. ,10
HaCaT human 22 n.t. ,10
Primary keratinocytes human 22 n.t. ,5
NHDF human (+) 2 n.t. ,5
Huvec human (+) 2 n.t. ,10
PFSK-1 human +++ +++ ++ ,40
LAN-1 human 22 n.t. ,10
IMR-32 human 22 n.t. ,10
Sy5y human 22 n.t. ,5
293 MCPyV LT human ++++ n.t. n.t. ,60
a: LT-Ag protein expression was tested by Immunoblotting 2d, 4d, 8d, 12d, 44d past transfection;
b: transcripts were tested at 2d, 4d, 8d and 12d p.t. using quantitative realtime PCR and normalized to GAPDH. n.t.: not tested.
c: Transfection efficiency was determined for each cell line using 100 ng GFP expression construct in 10
5 cells, 48 h p.t cells were analysed by FACS for GFP expression.
doi:10.1371/journal.pone.0029112.t001
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sequences) under the control of the CMV promoter. As shown in
the lower panel of Figure 4, after transfection of re-circularized
MCVSyn DNA these cells showed pronounced and continued
amplification of viral replicons, such that replicated episomes at 4
and 12 days post transfection were approximately 11 or 24 times,
respectively, more abundant than on day 2. Despite of this effective
DNA replication, however, we did not observe a CPE or (as
discussed later) production of infectious supernatants in these cells.
Late gene transcription and VP1 expression in MCVSyn-
transfected cells
Given our inability to observe a classical CPE and/or efficient
horizontal spread of viral infection in the tested cell cultures, we
next wondered whether late gene expression occurs in these cells.
We first analyzed VP1 as well as LT-Ag transcription at different
time points by performing quantitative realtime RT-PCR. As
shown in Figure 6, LT and VP1 transcripts were readily
detectable at day 2 in 293, H1299 as well as PFSK-1 cells. The
cell lines differ in the amount of transcripts produced, with 293
cells showing an approximately 10fold higher transcript level at 4
days post transfection. These results demonstrate that late gene
transcription does occur, but they do not exclude the possibility
that late gene products are not efficiently translated, fail to
localize in appropriate sub-nuclear compartments or do not
accumulate to levels that allow virion production. We therefore
analyzed VP1 protein expression and localization. We performed
wide field as well as confocal microscopy immunofluorescence
Figure 2. SV40 replication and gene expression in CV-1 cells transfected with SV40 DNA. (A) 100 ng of intramolecular religated SV40 viral
DNA was transfected in CV-1 cells and cells were lysed 12 h, 24 h, 36 h, 2d and 7d post transfection. Protein lysates were subsequently analyzed for
SV40 LT-Ag (Pab419 antibody) and VP1 expression (a-VP1 polyclonal rabbit serum) by SDS-page and Western Blotting. Staining of actin was used to
ensure that equal protein amounts were loaded per lane. (B) Low molecular weight DNA was isolated from SV40 DNA transfected CV-1 cells at the
indicated time points by HIRT extraction, 1 mg DNA was DpnI and EcoRI digested; DNA was separated on an agarose gel and stained with EtBr (left
panel), followed by southern blotting and detection of viral DNA using a
32PdCTP-labeled SV40 LT-Ag PCR fragment as a probe. The blot was exposed
for 30 min. Numbers below the lanes correspond to the quantification of newly replicated DNA using a Fuji phosphoimager FLA7000 and MultiGauge
software.
doi:10.1371/journal.pone.0029112.g002
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detect MCPyV VP1 in IFA and immunohistochemistry, kindly
provided by Christopher Buck (NIH) [18,19]. As before,
experiments were performed in parallel with SV40 transfected
CV-1 cells in order to directly compare VP1 protein expression
and localization.
As shown in Figure S5, at 48 h post transfection 50–60% of
CV-1 cultures transfected with SV40 DNA cells expressed LT-Ag
(given that the transfection efficiency in these experiments was
approximately 60%, this indicates that LT-Ag expression is
detectable in nearly 100% of the transfected cells). At the same
time, approximately half of these cells already express VP1
protein (Figure S5A). In Figure 7A, we present a confocal analysis
of the cells at 72 h post transfection. As expected LT-Ag, is
strictly nuclear with the nucleoli being excluded. In the majority
of cells LT-Ag was evenly distributed throughout the nucleus in a
speckled pattern, likely to represent sites of DNA replication
(center panels in Figure 7A). As shown in the left panels, in
accord with previous reports we detect SV40 VP1 predominantly
in speckles in the nuclear periphery or at the nuclear envelope,
where viral particles are thought to assemble and later
accumulate prior to the penetration of the nuclear membrane
[30,31,32].
The percentage of MCVSyn-transfected H1299 and PFSK-1
cells that displayed high-level expression of early or late MCPyV
antigens was significantly lower as in our SV40 experiments
(approximately 5% at 35–40% transfection efficiency; see Figure
S5 B). Similar to SV40 LT-Ag, the MCPyV LT-Ag localized to
nuclear speckles in H1299 as well as PFSK-1 cells (center panels of
Figure 7B and 7C, respectively). Although the MCPyV VP1
Figure 3. LT-Ag expression in human cell lines transfected with MCVSyn DNA. 5610
4 H1299, PSFK-1 or 293 cells were transfected with
100 ng re-circularized MCVSyn DNA or equivalent amounts of pUC18 DNA (Mock control). At the indicated time points, cells were lysed and analyzed
by immunoblotting for MCPyV LT-Ag expression using the monoclonal LT-Ag antibody Cm2B4. Equal protein loading was confirmed by re-incubating
the membrane with an anti-actin antibody. An LT-Ag expression control (pos. control; transient transfection with a CMV-promoter driven LT-Ag
expression construct for 48 h) was loaded as an internal control.
doi:10.1371/journal.pone.0029112.g003
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localizes to perinuclear regions, we did not observe the distinct
nuclear envelope localization seen in SV40 transfected CV-1 cells.
Likewise, only a few VP1-expressing cells display accumulation of
VP1 in speckles, similar to the cells shown in the upper left panel of
Figure 7B. These findings suggest that LT-Ag and VP1 protein are
correctly localized only in some MCVSyn-transfected H1299 and
PFSK-1 cells. However, as such cells were nevertheless consistently
detected, we hypothesized that at least a fraction of the transfected
cells should support MCPyV replication as well as virus assembly,
albeit the total amount of virion particles produced by the cultures
was expected to be muchlower than inSV40-transfected CV-1cells.
Detection of viral particles using density
ultracentrifugation and electron microscopy
In orderto detectvirion particles produced by H1299 and PFSK1
cells, we performed Optiprep
TM (Iodixanol) gradient ultracentrifu-
gation as described before [18]. Again, SV40-transfected CV-1 cells
were used as an internal standard. Fractions were analyzed by
western blotting for 45/90 kDa VP1 monomer and dimers, serving
as a marker for virion-containing fractions. Additionally, DNA
isolated from all fractions was subjected to micrococcal nuclease
digestion, followed by quantitative PCR using VP1 Primers.
As shown in Figure 8A, western blot analysis o with a SV40
VP1-specific polyclonal serum indicated the presence of virion
particles in fractions 6 to 12. The detection of VP1 perfectly
correlates with the realtime PCR-based detection of genomic
SV40 DNA in these fractions (Figure 8A). Negative staining of the
peak fraction (fraction 9) readily identified virion particles of
typical shape and size (approx. 45–50 nm; see right panels in
Figure 8A) by electron microscopy (EM).
Micrococcal-nuclease resistant viral DNA, indicative of en-
capsidated viral DNA, was also observed in identically prepared
gradient fractions from MCVSyn-transfected H1299 cells
(Figure 8B). Similar results were observed in PFSK-1 cells (data
not shown). However, consistent with the absence of cytopathic
effects and lack of horizontal spread, the DNA amounts in these
fractions were significantly (approx. 4–5 orders of magnitude)
lower than in SV40-transfected CV-1 cells (see Figures 8B and 8A,
respectively). The DNA was also more broadly distributed across
the gradient fractions, with sub-peaks appearing in the high-
molecular weight fraction 6, fraction 10 (which would be expected
to contain viral particles based on the SV40 results), as well as the
low molecular weight fraction 12. Indeed, as shown in the upper
and middle rows of the right panel in Figure 8B, using negative
EM staining we were able to detect particles that are likely to
represent MCPyV virions in fraction 10 of our H1299 gradient
preparations, although at much lower frequency than in SV40-
transfected CV-1 cells. Overall, the particles also seemed to be
somewhat smaller and of a slightly less regular/round shape than
SV40 virions (compare upper right panels in Figure 8A and -B).
Isolated particles were absent from fraction 6, despite of the
peak in viral DNA detected in these fractions. However, in accord
with the higher molecular weight of these fractions we observed
clusters of irregularly shaped, approximately 20–50 nm particles
that may represent aggregates of misshaped viral particles. We
were unable to detect any particles in the low molecular weight
fraction 13, indicating that the DNA in this fraction is not virion-
associated, but may rather be embedded in and protected by sub-
particle sized cellular debris or membrane structures.
Localization of electron-dense particles in cells
transfected with MCVSyn
Encouraged by the results from our negative staining EM, we
next attempted to detect cell-associated virions in ultrathin (50 nm)
resin sections of SV40 or MCVSyn-transfected cultures. 4 or 8
Figure 4. MCVSyn replication assays in H1299, PFSK-1 and 293 cells. 5 mg low molecular weight DNA isolated from cell cultures at the
indicated time points post-transfection with MCVSyn DNA was digested with DpnI and EcoRI, separated on an agarose gel and stained with EtBr (left
panels), then transferred via southern blot and probed with a radioactively labelled LT-Ag PCR fragment [13]. The blot was exposed for 24 h and
scanned using a Fuji phosphoimager FLA7000; MultiGauge software was used for quantification.
doi:10.1371/journal.pone.0029112.g004
Figure 5. R17a replication in PFSK-1 cells. 2 mg low molecular weight DNA from PFSK-1 cells transfected with MCVSyn or R17a viral DNA was
EcoRI and DpnI digested and separated on an agarose gel, followed by EtBr staining (left panel). The DNA was transferred via southern blotting and
probed with a radioactively labelled LT-Ag PCR fragment (right panel). The blot was exposed for 24 h.
doi:10.1371/journal.pone.0029112.g005
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respectively, cells were trypsinized and absorbed in cellulose
capillary tubes, followed by fixation, sectioning and EM analysis.
In the SV40-transfected CV-1 cultures, approx. 20% of the cells
were already lysed, and nearly all of the remaining cells showed
massive virion production. Figure 9A shows an isolated but intact
nucleus which is densely packed with viral particles, whereas
Figure 9B shows the border of two live cells from which virion
particles are shed and/or transmitted. We also frequently observed
beads-on-a-string like structures that appear to represent viral
particles associated with membranes; given the previously
observed nuclear rim-like VP1 staining patterns [30], these may
represent remnants of the nuclear envelope with fully assembled
virons that were in the process of penetration and nuclear egress at
the time of cell lysis (Figure 9C).
In Figure 10, we present an EM analysis of PFSK-1 cells at 8
days post-transfection with MCVSyn DNA. In line with our
previous observations, we were able to detect low-abundance
electron dense particles that were in the size range expected for
polyomavirus virions (Figure 10A). These particles were detected
only in approximately 1 out of 50 cells, and preferentially localized
to the nucleus and the nuclear periphery. We repeatedly observed
particles in close proximity to nuclear membranes (Figure 10B),
and also were able to detect particles attached to isolated,
membrane-like structures (Figure 10C), reminiscent of our
observations made in SV40-transfected CV-1 cells (compare
Figures 9C and 10C). However, as already observed in our
negative staining EM of gradient fractions, the MCPyV generally
seemed to be slightly smaller and of less regular shape than SV40
cells. Based on our EM analysis, we estimate that MCPyV
particles were at least 10,000 times less abundant than SV40
virions.
No serial transmission of infectious particles
As indicated above, we did not observe a typical CPE in our
MCVSyn-transfected cell cultures. Such an effect was also not
apparent when we cultured the cells for extended periods of time
(up to 48 days). Likewise, we did not observe evidence for
horizontal spread (i.e., cell to cell transmission) in our cultures, as
the total number of LT-Ag positive cells did not increase over time
(data not shown). When we incubated fresh cells with supernatants
transferred from MCVSyn-transfected H1299, PFSK1 or 293 cells
at various time points post transfection, we were unable to detect
early or late gene transcription, viral protein expression, or DNA
replication. We also considered the possibility that due to the
apparent absence of cell lysis, viral particles might not be
efficiently released from transfected cells. However, even after
multiple freeze/thaw cycles, we were unable to demonstrate serial
transmission. It has been suggested that ganglioside GT1b serves
as a receptor for MCPyV [33]. Although more recent data from
Schowalter and colleagues argue against GT1b supporting
attachment and/or entry for MCPyV, we nevertheless attempted
to increase the permissiveness of the recipient cultures by addition
of GT1b. Again, no serial transmission or viral spread was
observed.
Taken together, these data suggest that the amount of viral
particles is too low to achieve secondary infection, or that our
target cells miss the appropriate entry receptor. Additionally, given
the observed shape and size differences between MCPyV and
SV40 particles, it appears possible that the virions themselves may
be of low infectivity.
Discussion
Here, we report a side-by-side analysis of SV40 and MCPyV
replication, gene expression as well as virion production in a
number of different human and animal cell lines. For our study,
we generated a consensus MCPyV genome (termed MCVSyn)
based on the consensus from thirteen partial as well as complete
MCC-derived Merkel cell polyomavirus sequences. The fact that
this consensus sequence is identical to three wild type/field strains
isolated from human skin underlines the validity of our assumption
that such a consensus should represent an authentic system to
study the MCPyV lifecycle.
We observed that MCVSyn genomes readily undergo replica-
tion when transfected into a number of cell lines and/or primary
cells. Efficient replication as well as detection of LT-antigen,
however, was only seen in the three cell lines 293, H1299 and
PFSK-1. In another established line, Saos-2, as well two primary
cell cultures, HUVEC and NHDF, we failed to detect viral protein
expression, but reproducibly observed weak and transient
replication of transfected genomes (Figure S4).
It should be noted that the different cultures were naturally not
equally susceptible to plasmid transfection (see Table 1), a fact that
should be taken into account when comparing the absolute levels
of replicated episomes as shown in Figures 4 and S4. For example,
considering that transfection efficiencies in primary NHDF
cultures were roughly 10fold lower than in 293, H1299 and
PFSK-1 cells, it is likely that replication in primary dermal
fibroblasts per se is no less efficient as in the three established cell
lines (as discussed before, our failure to detect LT-Ag protein in
these cells is likely to be a result simply of the limited sensitivity of
our western blot detection).
Figure 6. Real-time PCR to quantify early and late gene transcripts in cells transfected with MCVSyn. RNA was isolated at the indicated
time points after transfection, DNAse I digested and used for cDNA synthesis followed by real time PCR using a LT-Ag or VP1 specific primer set.
Results were normalized against GAPDH transcript levels.
doi:10.1371/journal.pone.0029112.g006
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PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e29112Figure 7. Subcellular localization of LT-Ag and VP1 protein in cells transfected with religated viral DNA. (A) Double staining of CV-1
cells transfected with SV40 viral DNA. 4d p.t. the cells were fixed, and VP1 was detected with a polyclonal anti-VP1 antibody. LT-Ag was visualized
with the monoclonal anti-LT antibody Pab419. Z-stack pictures were taken using confocal microscopy. Each picture represents an individual Z-stack.
VP1 staining was observed primarily in speckles close to or at the nuclear membrane. LT-Ag staining was observed throughout the nucleoplasm with
the nucleoli excluded. In some cells granular LT-Ag staining was observed. The panel on the lower right represents a 36zoomed picture of a CV1
transfected cell with the two channels merged. Double staining of Merkel cell polyomavirus VP1 and LT-Ag in H1299 cells (B) and PFSK-1 cells (C) 4d
p.t. reveals inner peripheral nuclear localization of MCVSyn VP1 protein. VP1 was visualized with a polyclonal anti-VP1 serum and anti-rabbit FITC,
while LT-Ag was visualized with the monoclonal antibody Cm2B4 specifically recognizing MCPyV LT-Ag. 40 Z-stack pictures were taken scanning
through the cells using a 636magnification and 2fold zoom on a confocal microscope. The picture shown represents an individual image from the
center of a Z-stack.
doi:10.1371/journal.pone.0029112.g007
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no replication products were observed, despite of considerable
transfection efficiencies, indicating that these lines are indeed less
supportive of MCPyV replication, at least under conditions where
the viral genome is delivered by transfection. Whether this is due
to a failure to support early gene expression or origin-dependent
replication itself remains to be established. It may also be possible
that viral replication in some of these lines/cell types is negatively
affected by differential expression of host cell factors, similar to the
recently reported negative influence of the vacuolar sorting protein
hVam6p on MCPyV replication [27].
At first glance, when comparing Figures 3 and 4 it seems
counter-intuitive that H1299, 293 and PFSK-1 cells should
accumulate increasing amounts of replication products at late
time points post transfection, when at the same time LT-Ag
protein levels decline over time. However, it should be pointed out
that the bulk of LT-Ag expression at early time points is not
produced from the replicated genomes, but rather from the input
DNA that is sensitive to DpnI digestion and thus cleaved in the
replication assays (see the smaller band/cleavage product in
Figure 4). Thus, increased expression from accumulating replicat-
ed episomes is counterbalanced by a loss of expression from input
DNA, a fact that is also reflected by the near-constant LT-Ag
transcript levels as observed in Figure 6. It is likely that additional
factors influence LT-Ag protein expression. For example, MCPyV
has been shown to encode a microRNA (miRNA), mcv-mir-M1,
that is located antisense to LT-Ag and that, based on in vitro
luciferase assays, is able to negatively regulate LT-Ag expression
[16]. It appears that usage of such miRNAs is a conserved feature
of many polyomaviruses, a mechanism that presumably serves to
tone down LT-Ag protein expression and thereby limit exposure
of the infected cells to the immune system at late time points of
Figure 8. Density gradient centrifugation of SV40 and MCVSyn particles. Optiprep
TM gradient centrifugation was performed with cell
lysates from CV1 (A) and H1299 (B) cells 4d after transfection with viral DNA. 156250 ml fractions were collected (fraction 1 represents the fraction
with the highest density and fraction 15 represents the lowest density fraction). (A) Left panel: Real time PCR of micrococcal nuclease treated fractions
was performed using SV40 VP1 primer sequences. 20 ml of each gradient fraction was loaded on a 10% SDS-page followed immunoblotting using
anti-VP1 serum. Right panel: Negative EM staining of SV40 particles identified in fraction 9. (B) Left panel: Real time PCR results of H1299 MCVSyn
gradient fractions after micrococcal nuclease treatment using MCPyV VP1-specific primers. Right panel: Negative EM staining of particles identified in
fractions 10 and 6.
doi:10.1371/journal.pone.0029112.g008
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PLoS ONE | www.plosone.org 12 December 2011 | Volume 6 | Issue 12 | e29112infection (for a recent review on viral miRNAs, see [34]). While we
verified that mcv-mir-M1 is expressed in our system (data not
shown), we did not explicitly test to what extend it may contribute
to the observed drop in LT-Ag protein levels. Further studies will
be necessary to investigate the precise role of mcv-mir-M1 in the
MCPyV lifecycle.
Regardless of the mechanism that leads to the decline of LT-Ag
expression over time, we observed that stable co-expression of the
early region of MCPyV resulted in significantly increased
replication in 293 cells. As the early gene region is capable of
expressing small as well as large T antigens, it is unclear whether
this effect is due to the trans-complementation of LT-Ag loss, or
reflects the indirect contribution of elevated ST-Ag levels to viral
replication; a recent study suggests that the latter may be the case
[27]. As noted before and shown in Figure 1, with the exception of
LT-Ag truncating mutations in MCC-derived genomes, nucleotide
insertions and deletions among MCPyV isolates are mainly
observed in the non-coding control region (NCCR) of the virus,
including the replication core. Some of these mutations have been
shown to positively affect viral replication, such as the duplication
of a GGGNGGRR motif present in the MCPyV strains TKS and
16b [7,35]. We compared MCVSyn to another field isolate, R17a,
which differs from the consensus sequence only in the deletion of a
single nucleotide in the core origin; the same deletion is also
present in isolate 09b. Interestingly, the R17a isolate replicated
with a markedly lower efficiency than the MCVSyn genome
(Figure 5), indicating that replication efficiency may indeed differ
significantly among field isolates of Merkel cell polyomavirus.
Although we did not observe cytopathic effects/cell lysis or
serial transmission, using electron microscopy we were neverthe-
less able to detect viral particles with a diameter of approximately
40 nm in MCVSyn transfected cells, both by negative staining of
gradient fractions as well as in intact cells. In accord with the
results from our replication and expression analyses, virions were
much less abundant than in SV40-transfected CV-1 cells. For
gradient fractions as well as cell-bound virions, we found MCPyV
particles to be slightly smaller (40 nm) and of a less regular shape
than SV40 particles; while both could be intrinsic properties of
MCPyV virions, this observation suggested to us that the particles
produced in this system might not be completely mature, which
may in part explain the lack of serial transmission.
Polyomavirus replication, especially in the SV40 system, is well
studied, however far less is known about virus assembly and the
particular signals that trigger and control this process. We observe
efficient expression of VP1 protein in the nucleus of SV40 DNA
transfected CV-1 cells, and at 72 h post transfection find the
protein to localize almost exclusively at the nuclear rim. Similar
data are known from JC Virus where VP1 localization is also
reported at the nuclear rim in granular structures most likely
resembling sites of virus assembly [32]. Although we were unable
to directly compare VP1 protein expression levels by western
blotting, in immunofluorescence analyses of MCVSyn-transfected
cells we observed VP1 staining as early as 4d post transfection.
Interestingly, although strictly nuclear, MCPyV VP1 protein
localizes to more perinuclear regions in the nucleus, and not
strictly at the nuclear envelope. Similar localization pattern of VP1
proteins has been observed for JC-reporter mutants that
overexpress the complete late gene region but lack VP3 protein
[32]. It has been speculated that, due to a lack of the conserved
Met-Ala-Leu motif that has been identified in all polyomavirus
VP3 proteins so far, a functional VP3 protein might not be present
in MCPyV [18]. For SV40, perinuclear staining of VP1 protein
has been reported in the absence of the agnoprotein, which is also
important for viral release [36,37]. As no agnoprotein has been
annotated for the MCPyV sequence [2,13], both the potential lack
of a functional VP3 protein as well as an agnoprotein may impede
proper localization of the VP1 protein, at least in the cell types and
replication system tested here. Lastly, we note that proper timing
of viral gene expression may be a factor that could contribute to
the efficiency of virion assembly. Especially since polyomavirus
particles package chromatinized genomes, it is likely that fine
tuning of the viral gene expression program may differ from the
transfection of naked DNA. Ultimately, the answer to this question
will have to await the availability of a system that is fully permissive
for viral infection.
While our manuscript was in preparation, two studies
investigating MCPyV replication and transmission in vitro were
reported [27,38]. Feng and colleagues used an approach very
similar to ours, i.e. a consensus viral genome that is identical in
sequence to MCVSyn, to study viral replication and transmission
in 293 cells [27]. In agreement with our data, Feng et al. observed
DNA replication and particle production, but no serial transmis-
sion. Schowalter et al. performed gradient-purification and
enrichment of virion-containing fractions from freeze/thawed
293-4T cells (293T cells that stably express an extra copy of SV40
LT-Ag, as well as the small and large T Antigens of Merkel cell
polyomavirus) transfected with R17a genomes [27,38]. Using this
highly optimized system, the authors were able to detect an
increase of viral DNA relative to input DNA when the enriched
fractions were transferred to fresh cultures of 293-4T cells,
suggesting replication of genomes delivered by infectious virions.
However, in agreement with our data and those of Feng et al., the
observed two-fold enrichment of genomic DNA over input DNA
suggests a low efficiency of transmission. While we did not attempt
to detect viral particles produced by R17a-genomes, we did ensure
that LT-Ag and VP1 expression and localization do not differ
fundamentally between MCVSyn- and R17a-transfected H1299
and PFSK-1 cells (Figure S6). Given the higher DNA replication
efficiency observed in our replication assays (Figure 5), it will
therefore be interesting to test the MCVSyn genome in highly
sensitive infection systems such as the one used by Schowalter et al.
[27,38].
In summary, the semi permissive in vitro replication system
reported here provides an excellent starting point for further
analyses of the MCPyV lifecycle. The availability of genetically
tractable genomic clones such as MCVSyn will greatly facilitate
the study of the role of viral as well as cellular factors during
Merkel cell polyomavirus replication, virion assembly and egress.
Materials and Methods
Cell lines and tissue culture
Human cell lines 293 cells, 293T cells [39], Bea2b cells (ATCC,
CRL-9609), H1299 cells [40], Saos-2 cells [41], A549 [42],
HaCaT cells [43], HeLa cells (ATCC, CCL-2) and mouse N2A
cells (ATCC, CCL-131), were grown as monolayer cultures in
Figure 9. Electron micrographs of viral particles in SV40-transfected CV-1 cells. Images were prepared from CV-1 cultures at 4 days post
transfection with SV40 DNA. (A) Accumulation of SV40 particles in an isolated nucleus of CV-1 cell cultures. (B) Particles close to the plasma
membrane and projecting into the intercellular space between two CV-1 cells potentially represent a cell-to-cell transmission event of SV40 particles.
Such events were rarely detected. (C) Large numbers of SV40 viral particles attached to membranous structures.
doi:10.1371/journal.pone.0029112.g009
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10% fetal calf serum (FCS) and 5% penicillin/streptomycin in a
5% CO2 atmosphere at 37uC. Human PFSK-1 cells (ATCC,
CRL-2060), the human neuroblastoma cell lines LAN-1 [44],
IMR-32 [45] and SH-SY5Y [46] and African green monkey CV1
(ATCC, CCL-70), Vero cells (ATCC, CCL-81), and COS7 cells
(ATCC, CRL-1651) were grown in RPMI medium supplemented
with 10% FCS and 5% penicillin/streptomycin. HUVEC cells
were maintained in endothelial cell basal medium (Cambrex,
Bioscience) supplemented with 10% FCS and EGM Single Quots
(Cambrex Bioscience). Only cells maintained for 5 to 10 passages
were used in experiments.
Normal human dermal fibroblasts (NHDF) were purchased
from Lonza, cultured in fibroblast ready to use growth medium
supplemented with FCS and insulin (Lonza). Primary human
keratinocytes (Lonza) were maintained in keratinocyte basal media
supplemented with the corresponding BulletKit. 293 cells stably
expressing MCPyV LT- Ag were generated by transfection of cells
with linearized pCMV2a-MCPyV LT [47] followed by bulk
selection using G418.
Plasmids and transfection methods
To generate the synthetic clone MCVSyn, we first generated a
MCPyV consensus sequence by aligning 13 partial and complete
MCC-derived MCPyV sequences (see below for accession
numbers) deposited in the NCBI database as of June 2008. The
CLUSTAL W algorithm was used to produce the alignments, and
sequence conflicts were resolved by majority vote among the
individual isolates. The resulting MCVSyn consensus sequence
was assembled synthetically in two fragments inserted into the
cloning vector pMK (GeneART, Regensburg). pMK-MCVSyn-A
contains nucleotides 1549-4540, whereas pMK-MCVSyn-B
contains nucleotides 4528-1580 of the MCVSyn genome. In both
constructs, the inserts are flanked by PacI and/or SacI sites (see
Figure S1). A complete synthetic MCVSyn genome in which the
early region is disrupted by the pMK vector backbone sequence,
pMK-MCVSyn, was constructed by releasing a 2452 bp from
pMK-MCVSyn-B by PacI digestion, and inserting it into the PacI-
linearized pMK-MCVSyn-A vector. To produce circularized
MCVSyn DNA for transfection, the viral genome was released
from pMK-MCVSyn by SacI digestion (Figure S1). Subsequently,
intramolecular ligation of viral DNA was performed using T4
DNA Ligase overnight, followed by column purification of
recircularized DNA as described [48]. The sequences of
pMCVSyn and MCVSyn have been deposited in GenBank
(accession numbers JN707598 and JN707599, respectively).
Full-length genomes of SV40 and MCPyV isolate R17a
(GenBank accession HM011555.1) were produced via EcoRI- or
BamHI-mediated excision from plasmids pMCV-R17a [7] or
pSV40 [49], respectively, followed by intramolecular religation of
the viral DNA using T4 DNA Ligase and subsequent column
purification of the circularized DNA [48]. Plasmid pMCV-R17a
was created by Schowalter et al. [7] and was obtained from
Addgene (www.addgene.org, plasmid #24729). pSV40 [49] was
generously provided by Wolfram Deppert, Heinrich-Pette Insti-
tute, Hamburg. pCMV2-MCPyV LT encodes LT- as well as ST-
Ag and of MCPyV and was generated by PCR amplification of the
early gene region from re-circularized MCVSyn DNA, using
primers MCPyV_EcoRV_F and XhoI MCPyV_XhoI_R (see
Table S2 for primer sequences) and the taqExpand PCR
amplification system (Roche Diagnostics). Plasmid pwM [7]
expresses a codon optimized MCPyV VP1 ORF (GenBank
accession FJ548568) and was obtained from Addgene (plasmid
#22515).
HUVEC cells were transfected using the Neon
TM nucleofactor
system (Invitrogen), and HaCaT as well as primary human
keratinocytes were transfected by AMAXA Nucleofector II
technology, following the manufacturer’s instructions. All other
cell lines were transfected using the FuGENE HP transfection
reagent (Roche diagnostics) according to the manufacturer’s
instructions. Saos-2 cells were transfected in the presence of
ExGen500 (Fermentas Inc.).
Sequence analysis
Multiple sequence alignments and generation of phylogenetic
trees were performed using the ClustalW2 server at EMBL-EBI
(www.ebi.ac.uk/Tools/msa/clustalw2). The accession numbers
for all sequences used in the analyses shown in Figs. 1 and S1
are given in Table S3. The following MCC-derived MCPyV
sequences were used to build the MCVSyn consensus genome (see
Table S3 for accession numbers): MCC206, MCC322, MCC339,
MCC344, MCC345, MCC347, MCC348, MCC349, MCC350,
MCC352, MCC366, MCC85, MKL-1.
Viral DNA Replication assay
1610
5 cells were transfected with 100 ng MCVSyn DNA and
250 ng carrier DNA (pUC18) or equivalent amounts of carrier
DNA only (mock control). At 2, 4, 8 and 12d post transfection, low
molecular weight DNA was purified by HIRT extraction as
described before [50]. 1 mg of the isolated DNA was digested with
DpnI and EcoRI for 30 min at 37uC (FASTdigest, Fermentas) and
separated on a 0.8% DNA Agarose gel. DNA was transferred to
Hybond N+ membrane (GE Healthcare) and analyzed by
Southern blot analysis using a
32P dCTP labelled PCR amplified
LT-fragment (rediPrime, GE Healthcare) resuspended in UL-
TRAhyb Solution (Ambion) as a probe. THe primers used to
generate the probes were MCPyV-LT-s and MCPyV-LT-as (see
Table S2). Blots were hybridized for 16 h at 42uC and
subsequently washed 2615 min 2%SSC, 0.1%SDS followed by
1615 min 0.26SSC, 0.1%SDS at 42uC. Blots were exposed for
24 h and subsequently scanned using Fuji phosphoimager
FLA7000 and MultiGauge software.
Antibodies and Western Blotting
Cells were resuspended in lysis buffer (50 mM Tris pH 8.0,
150 mM NaCl, 1% NP40, 0.5% Na-Deoxycholat, 5 mM EDTA,
0.1% SDS, proteinase inhibitor cocktail, Roche). 25 mg total
protein per lane was separated by 10% SDS PAGE and blotted on
a PVDF membrane. Primary antibodies specific for polyomavirus
proteins used in this study and their suppliers were: mouse
monoclonal (mAb) MCPyV LT-Ag antibody Cm2B4 [14] (Santa
Cruz), mouse monoclonal SV40 LT antibody Pab419 [51] (Santa
Cruz) and MCPyV VP1 rabbit polyclonal antiserum [18]
generously provided by Chris Buck, NIH. An actin mAb
(Chemicon Cat.No. 1501) was used to ensure equal protein
amounts loaded. Secondary antibodies conjugated to horseradish
Figure 10. Electron micrographs of viral particles in MCVSyn-transfected PFSK-1 cells. Images were prepared from PFSK-1 cultures at 8
days post transfection with MCVSyn DNA. (A and B) ,40 mm electron dense particles were observed in approximately 1 out of 50 cells with the
particles localizing in the nucleus close to membrane structures (additional particles in B that are located outside of the enlarged inset are marked by
arrows). (C) Membrane-attached MCPyV particles, reminiscent of the structures observed in SV40 infected cells as shown in Figure 9C.
doi:10.1371/journal.pone.0029112.g010
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were anti-mouse IgG (GE Healthcare) and anti-rabbit IgG (Santa
Cruz).
Immunofluorescence staining and confocal microscopy
For indirect immunofluorescence, cells were grown on glass
cover slips coated with 0.2% gelatine (Sigma). Cells were fixed in
4% paraformaldehyde in PBS (15 min) and permeabilized in PBS,
3% Triton X-100 for 30 min. After 1 h blocking in PBS
containing 1% Triton X-100, 0.5% Tween, 3% BSA (Albumin
fraction) buffer, coverslips were incubated for 3 h with the primary
antibodies diluted in blocking buffer, washed in PBS, followed by
incubation with the corresponding fluorophor conjugated second-
ary antibodies (Dianova, Hamburg, Germany). Coverslips were
mounted in vectashield medium containing DAPI (Vectashield)
and digital images were acquired with a confocal laser-scanning
microscope (Leica DM IRE2 with a Leica TCS SP2 AOBS
confocal point scanner) equipped with an oil-immersion plan Apo
636NA 1.4 objective.
Determination of LT and VP1 transcript by quantitiative
PCR
Total RNA of MCVSyn transfected or MOCK transfected cells
was isolated using the RNeasy extraction kit (Qiagen,
CatNo. 74104) according to manufacturer’s instructions. DNaseI
digest was performed following the on-column protocol provided
by Qiagen. 500 ng total RNA was reverse transcribed with a
random hexamer primer and the SuperScriptTM Reverse
Transcriptase (Invitrogen, CatNo. 18064-014). cDNA levels were
determined using a Rotorgene Q 5plex instrument (Qiagen) and
Rotorgene 1.7 software. Reactions were performed in microtubes
containing 5 ml2 6 SyBr Green mastermix (Fermentas), 3.8 ml
H2O, 0.1 ml primer and 1 ml (20 ml) cDNA. Primer sequences,
annealing temperatures and PCR efficiency are listed in Table S2.
PCR efficiency of each primer set was determined by standard
curves of serial 10fold dilutions of plasmid DNA (LT: pCMV-
MCPyV LT; VP1: pCMV-MCPyV VP1. Ct values (determined
by the Rotorgene Software version 1.7) were plotted against the
log10 value of template concentration, with the slope (M)
determining the reaction efficiency according to the formula (10-
1/M)-1=1. Relative expression levels were calculated by incor-
porating the PCR efficiency according to the Rotorgene Software
version 1.7. Relative mRNA levels were normalized to GAPDH
(see Table S2 for the primer sequence).
Transmission electron microscopy
For ultrastructural analysis of virus assembly processes cellulose
capillary tubes of 200 mm diameter [52] were filled with cells 4–6d
past transfection with viral DNA for 4–6d by capillary attraction
and mechanically sealed at both ends using the blunt side of a
scalpel. Chemical fixation of the cells was accomplished by
incubating the highly porous tubes (molecular weight cut-off limit
10 kDa) with 2.5% glutaraldehyde (GA) in PBS for 30 minutes at
room temperature. Subsequently, the cells were washed with PBS,
postfixed for 30 minutes with 1% OsO4 in PBS, washed with
ddH2O, and stained with 1% uranyl acetate in water. The samples
were gradually dehydrated with ethanol and embedded in Epon
resin (Carl Roth, Germany) for sectioning. Ultrathin 50 nm
sections were prepared using Ultracut Microtome (Leica Micro-
systems, Germany). The sections were counterstained with 2%
uranyl acetate and lead citrate.
For negative staining, 15 ml of the different purified virus
fractions were applied on Parafilm and covered with a glow
discharged carbon-coated Formvar grid (mesh size, 200) for
15 min. After adsorption, grids were fixed with glutaraldehyde
2.5% for 2 min, were washed three times with aqua dest. and
stained with 2% uranyl actetate for 5 min. Excess stain was soaked
off by touching the grid to a filter paper. After staining, the grids
were air dried. Electron micrographs were obtained with a FEI
Eagle 4 k HS CCD camera attached to a FEI Technai G 20 Twin
Transmission Electron Microscope (FEI, Eindhoven, The Nether-
lands) at 80 kv.
Purification of virion particles by ultracentrifugation
using OptiPrep
TM
4d p.t. cells transfected with viral DNA were lysed (PBS
supplemented with 9.5 mM MgCl2, 0.5% Triton X-100, 1% pen-
strep-mix (Gibco), 0.1% RNaseA) and incubated over night at
37uC to support particle formation. After the lysate was clarified
by centrifugation (2610 min at 10,000*g), 120 ml of lysate was
loaded onto an OptiPrep
TM (iodixanol) gradient (27-33-39%) as
described [53] and centrifugated for 4 h at 52,000 rpm using an
SW60Ti Rotor. Tubes were punctured and 250 ml fractions were
collected. Fractions were analyzed for the presence of SV40
virions using Western Blotting, applying a VP1 antibody (a-SV40
VP1 polyclonal serum kindly provided by Wolfgang Deppert,
Heinrich-Pette Institute, Hamburg), or by testing the fractions for
infection of CV-1 cells (successful infection was monitored by IFA
or CPE). All fractions were micrococcal nuclease treated by
incubating 20 ml of the fraction with 40 U micrococcal nuclease
for 1 h at 37uC, followed by stopping of the reaction with EGTA.
Undigested/virion incorporated DNA was extracted by Phenol/
Chloroform extraction, followed by Chloroform/Isoamylalcohol
extraction and Ethanol precipitation. DNA was resuspended in
20 ml water and 1/10
th was analyzed by realtime PCR using the
primers listed in Table S2. In the case of Merkel cell polyomavirus,
fractions were analyzed for the presence of MCPyV particles by
negative EM staining.
SV40 virus production
CV1 cells were seeded at 40–50% confluence one day prior
infection in 10 cm dish. Medium was replaced with 1.5 ml
medium containing SV40 cell lysate (passed through a 0.45 mm
filter) MOI 0.1. After 2 h incubation at 37uC in an incubator, 8 ml
fresh culture medium was added. Cells were harvested once a
complete CPE was visible. Cells and floating cell debris were
transferred to a T75 culture flask and three cycles of freeze and
thawing of the cells was performed. Cellular debris was removed
by centrifugation (200RCF 5 min) and serial dilutions were
generated to determine SV40 Titer. Titering was performed by
infecting CV-1 cells and subsequent immunofluorescence analysis
for the expression of LT-Ag 36 h p.i.
Serial transmission of MCPyV using lysates from MCPyV
transfected cells
Virus lysates were generated by resuspending 5610
5 MCPyV-
transfected cells at 4d p.t. in 500 ml culture medium, performing
three freeze/thaw cycles followed by removal of cellular debris
through low speed centrifugation or passing through a 0.45 mm
filter. Prior to the day of infection, 5610
4 cells of 293, PFSK-1 and
H1299 were seeded in 12well plates. On the day of infection
culture medium was replaced with 500 ml medium containing
500 ml, 250 ml, 100 ml and 50 ml of virus lysates from 293, PFSK-1
or H1299 cells, in the presence or absence of polybrene at a final
concentration of 8 mg/ml. GT1b (Sigma) was added (3.2 mM final
concentration) 18 h prior infection. Infected cultures were
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cence for viral gene products and viral DNA replication assays.
Supporting Information
Figure S1 Generation of the consensus MCVSyn ge-
nome. The consensus MCPyV genome was synthesized as two
separate fragments which were inserted into the cloning vector
pMK: pMK-MCVSyn-B contains nucleotides 4528-1580 flanked
by PacI restriction sites; whereas pMK-MCVSyn-A contains
nucleotides 1549-4540 (all nucleotide positions are given relative
to GenBank entry HM011549). The MCVSyn-B PacI insert was
cloned into the PacI-linearized pMK-MCVSyn-A to create pMK-
MCVSyn, a construct which carries the complete MCPyV
genome with the early gene region being disrupted by the vector
backbone- A 13 bp duplication that contains a SacI site is present
on each side of the viral genome and can be used to release the
MCVSyn genome, followed by intramolecular recircularization
using T4 DNA Ligase.
(TIF)
Figure S2 Phylogenetic tree of full length MCPyV
genomes including MCVSyn. Phylogenetic analysis of
MCVSyn and all full length MCPyV sequences deposited in the
NCBI Database as of August 2011 (see Table S3 for accession
numbers).
(TIF)
Figure S3 Cytopathic effect (CPE) of CV-1 cells trans-
fected with SV40 viral DNA. CV-1 transfected with SV40
DNA start to show irregular round shaped cells which are enlarged
and contain dense bodies at 4 days post transfection. Cells start to
detach at day 6, and cultures are completely lysed by day 11.
(TIF)
Figure S4 MCVSyn replication assays in HUVEC,
NHDF and Saos-2 cells. Low molecular weight DNA was
isolated by HIRT extraction, 1.5 mg (HUVEC), 1 mg (NHDF) or
2 mg (Saos-2) DNA was DpnI and EcoRI digested, separated on
an agarose gel and transferred to Hybond N+ membrane. DNA
was probed with a radioactively labelled LT-Ag PCR fragment.
The Blot was exposed for 24 h and scanned using Fuji
phosphoimager FLA7000 and MultiGauge software.
(TIF)
Figure S5 VP1 and LT double staining in SV40 transfected CV-
1 cells (A) and MCVSyn transfected H1299 cells (B). Cells
transfected with intramolecular religated viral DNA were fixed at
4 day post transfection. VP1 was visualized with specific rabbit
polyclonal VP1 antisera and anti-rabbit FITC staining while LT-
Ag was visualized using specific monoclonal Ab and subsequent
anti-mouse TRITC staining. DNA was stained by DAPI.
(TIF)
Figure S6 Detection of LT-Ag and VP1 in an replication
assay using religated R17a viral DNA in H1299 and
PFSK-1 cells. Cells were transfected with 100 ng religated DNA;
4d.p.t. cells were examined for LT-Ag expression and VP1 protein
expression by immunofluorescence double staining. VP1 protein
was visualized using polyclonal rabbit anti-VP1 serum and anti-
rabbit FITC, whereas LT-Ag was visualized using monoclonal
mouse Cm2B4 antibody and anti-mouse TRITC. Z-stack pictures
were taken at 636 magnification, 26 zoom using confocal
microscopy. Each picture represents an image from a single
image from a Z-stack. VP1 staining was observed throughout the
nucleoplasm, with some protein localizing to subnuclear speckles
while LT-Ag staining was observed as granular staining through-
out the nucleus.
(TIF)
Table S1 Sequence variation between MCVSyn and MCPyV
isolates R17a, R17b and R30a.
(PDF)
Table S2 Summary of primer sequences and PCR conditions.
(PDF)
Table S3 Accession numbers.
(PDF)
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